Cost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and Wales

Mattock, R orcid.org/0000-0001-7517-5233, Gibbons, I, Moss, J et al. (4 more authors) (2021) Cost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and Wales. Journal of Medical Economics, 24 (1). pp. 1261-1271. ISSN 1369-6998

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
Keywords: adjuvant; cost-effectiveness; High dose; influenza; trivalent; vaccine
Dates:
  • Accepted: 28 October 2021
  • Published (online): 2 November 2021
  • Published: 2 November 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Academic Unit of Health Economics (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 19 Nov 2021 16:14
Last Modified: 26 Jul 2022 13:28
Status: Published
Publisher: Taylor and Francis
Identification Number: https://doi.org/10.1080/13696998.2021.2000780

Download

Share / Export

Statistics